» Articles » PMID: 35175354

Matrix-induced Autologous Chondrocyte Implantation (mACI) Versus Autologous Matrix-induced Chondrogenesis (AMIC) for Chondral Defects of the Knee: a Systematic Review

Overview
Journal Br Med Bull
Specialty General Medicine
Date 2022 Feb 17
PMID 35175354
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Chondral defects of the knee are common and their treatment is challenging.

Source Of Data: PubMed, Google scholar, Embase and Scopus databases.

Areas Of Agreement: Both autologous matrix-induced chondrogenesis (AMIC) and membrane-induced autologous chondrocyte implantation (mACI) have been used to manage chondral defects of the knee.

Areas Of Controversy: It is debated whether AMIC and mACI provide equivalent outcomes for the management of chondral defects in the knee at midterm follow-up. Despite the large number of clinical studies, the optimal treatment is still controversial.

Growing Points: To investigate whether AMIC provide superior outcomes than mACI at midterm follow-up.

Areas Timely For Developing Research: AMIC may provide better outcomes than mACI for chondral defects of the knee. Further studies are required to verify these results in a clinical setting.

Citing Articles

No Difference in Chondrocyte Viability Using Manual Versus Custom-Cutting Technique for Matrix-Induced Autologous Chondrocyte Implantation.

Chang W, Atzmon R, Vel M, Lin K, Abrams G, Sherman S Orthop J Sports Med. 2025; 13(2):23259671241308855.

PMID: 39931633 PMC: 11808760. DOI: 10.1177/23259671241308855.


Emerging Strategies in Cartilage Repair and Joint Preservation.

Focsa M, Florescu S, Gogulescu A Medicina (Kaunas). 2025; 61(1).

PMID: 39859006 PMC: 11766557. DOI: 10.3390/medicina61010024.


Factors Affecting Choice of Surgical Treatment of Cartilage Lesions of the Knee: An Analysis of Data From 5143 Patients From the German Cartilage Registry (KnorpelRegister DGOU).

Gebhardt S, Vollmer M, Zimmerer A, Rochel I, Balcarek P, Niemeyer P Orthop J Sports Med. 2024; 12(7):23259671241255672.

PMID: 39070901 PMC: 11273558. DOI: 10.1177/23259671241255672.


A novel scaffold-free mesenchymal stem cell-derived tissue engineered construct for articular cartilage restoration - From basic to clinic.

Shimomura K, Ando W, Hart D, Nakamura N Regen Ther. 2024; 26:124-131.

PMID: 38883147 PMC: 11176953. DOI: 10.1016/j.reth.2024.05.007.


Knee Joint Preservation in Tactical Athletes: A Comprehensive Approach Based upon Lesion Location and Restoration of the Osteochondral Unit.

Cognetti D, DeFoor M, Yuan T, Sheean A Bioengineering (Basel). 2024; 11(3).

PMID: 38534520 PMC: 10967907. DOI: 10.3390/bioengineering11030246.


References
1.
Bartlett W, Skinner J, Gooding C, Carrington R, Flanagan A, Briggs T . Autologous chondrocyte implantation versus matrix-induced autologous chondrocyte implantation for osteochondral defects of the knee: a prospective, randomised study. J Bone Joint Surg Br. 2005; 87(5):640-5. DOI: 10.1302/0301-620X.87B5.15905. View

2.
Astur D, Lopes J, Santos M, Kaleka C, Amaro J, Cohen M . Surgical treatment of chondral knee defects using a collagen membrane - autologus matrix-induced chondrogenesis. Rev Bras Ortop. 2018; 53(6):733-739. PMC: 6205011. DOI: 10.1016/j.rboe.2018.09.005. View

3.
Saris D, Price A, Widuchowski W, Bertrand-Marchand M, Caron J, Drogset J . Matrix-Applied Characterized Autologous Cultured Chondrocytes Versus Microfracture: Two-Year Follow-up of a Prospective Randomized Trial. Am J Sports Med. 2014; 42(6):1384-94. DOI: 10.1177/0363546514528093. View

4.
Hinckel B, Gomoll A . Autologous Chondrocytes and Next-Generation Matrix-Based Autologous Chondrocyte Implantation. Clin Sports Med. 2017; 36(3):525-548. DOI: 10.1016/j.csm.2017.02.008. View

5.
Migliorini F, Berton A, Salvatore G, Candela V, Khan W, Longo U . Autologous Chondrocyte Implantation and Mesenchymal Stem Cells for the Treatments of Chondral Defects of the Knee- A Systematic Review. Curr Stem Cell Res Ther. 2020; 15(6):547-556. DOI: 10.2174/1574888X15666200221122834. View